Earnings Feed
Start Free
Home/Filings/4/0000899243-17-012696
4//SEC Filing

AMEDISYS INC 4

Accession 0000899243-17-012696

CIK 0000896262operating
View on SEC.govCompany Profile

Filed

May 9, 8:00 PM ET

Accepted

May 10, 9:46 PM ET

Size

34.9 KB

Accession

0000899243-17-012696

Insider Transaction Report

Form 4
Period: 2017-05-08
AMEDISYS INCAMED
Pernosky Lawrence R
Chief Human Resources Officer
Transactions
  • Sale

    Common Stock

    2017-05-08$58.65/sh−12,281$720,281→ 17,812 total
  • Sale

    Common Stock

    2017-05-09$58.75/sh−10,900$640,375→ 18,412 total
  • Exercise/Conversion

    Common Stock

    2017-05-10$27.35/sh+5,626$153,871→ 25,562 total
  • Sale

    Common Stock

    2017-05-10$58.99/sh−11,300$666,587→ 18,012 total
  • Sale

    Common Stock

    2017-05-08$58.45/sh−214.99$12,566→ 0 total(indirect: By 401(k))
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-05-10−2,124→ 22,500 total
    Exercise: $27.35Exp: 2025-05-01→ Common Stock (2,124 underlying)
  • Exercise/Conversion

    Common Stock

    2017-05-09$27.35/sh+11,500$314,525→ 29,312 total
  • Sale

    Common Stock

    2017-05-09$59.25/sh−600$35,550→ 17,812 total
  • Sale

    Common Stock

    2017-05-10$57.83/sh−200$11,566→ 17,812 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-05-10−5,626→ 5,624 total
    Exercise: $27.35Exp: 2025-05-01→ Common Stock (5,626 underlying)
  • Exercise/Conversion

    Common Stock

    2017-05-08$27.35/sh+8,876$242,759→ 30,093 total
  • Exercise/Conversion

    Common Stock

    2017-05-10$27.35/sh+2,124$58,091→ 19,936 total
  • Exercise/Conversion

    Common Stock

    2017-05-10$27.35/sh+3,750$102,563→ 29,312 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-05-08−8,876→ 36,124 total
    Exercise: $27.35Exp: 2025-05-01→ Common Stock (8,876 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-05-09−11,500→ 24,624 total
    Exercise: $27.35Exp: 2025-05-01→ Common Stock (11,500 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-05-10−3,750→ 7,500 total
    Exercise: $27.35Exp: 2025-05-01→ Common Stock (3,750 underlying)
Footnotes (8)
  • [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.30 to $59.06, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), and (5) to this Form 4.
  • [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.20 to $59.01, inclusive.
  • [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.22 to $59.29, inclusive.
  • [F4]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.62 to $59.27, inclusive.
  • [F5]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.70 to $57.96, inclusive.
  • [F6]The reporting person was granted 45,000 time-based stock options (the "Time-Based Stock Options") on May 1, 2015. The Time-Based Stock Options are subject to time-based vesting conditions. The Time-Based Stock Options vested in equal, 25% installments on each of May 1, 2016 and May 1, 2017 and will vest in equal, 25% installments on each of May 1, 2018 and May 1, 2019, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Time-Based Stock Options.
  • [F7]On May 1, 2015, the reporting person was granted 11,250 performance-based stock options (the "2015 Tranche Stock Options") that were subject to achievement of identified performance goals for fiscal year 2015, which the Compensation Committee of the Issuer's Board of Directors has certified as achieved. The 2015 Tranche Stock Options are subject to additional time-based vesting conditions (2,813 vested on May 1, 2016, 2,813 vested on May 1, 2017, 2,812 will vest on May 1, 2018 and 2,812 will vest on May 1, 2019), assuming the Reporting Person remains continuously employed by the Issuer on such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the 2015 Tranche Stock Options.
  • [F8]On May 1, 2015, the reporting person was granted 11,250 performance-based stock options (the "2016 Tranche Stock Options") that were subject to achievement of identified performance goals for fiscal year 2016, which the Compensation Committee of the Issuer's Board of Directors has certified as achieved. The 2016 Tranche Stock Options are subject to additional time-based vesting conditions (one-third vested on May 1, 2017, and one-third will vest on each of May 1, 2018 and May 1, 2019), assuming the Reporting Person remains continuously employed by the Issuer on such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the 2016 Tranche Stock Options.

Documents

1 file

Issuer

AMEDISYS INC

CIK 0000896262

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000896262

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 9:46 PM ET
Size
34.9 KB
View on SEC.gov